Trial intelligence / Profile preview

S-707106 in Type 2 Diabetes Mellitus with Inadequate Metformin Control

NCT01240759Phase 2Completed

Sponsor
Shionogi & Co., Ltd.
Start
Oct 2010
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of S-707106 in type 2 diabetes mellitus (T2DM), sponsored by Shionogi & Co., Ltd.. Started Oct 2010; status: completed.

02

Drugs

S-707106
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01240759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01240759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call